Literature DB >> 26609961

Catalytic Enantioselective Nitroso Diels-Alder Reaction.

Biplab Maji1, Hisashi Yamamoto1.   

Abstract

The nitroso Diels-Alder (NDA) reaction is an attractive strategy for the synthesis of 3,6-dihydro-1,2-oxazines and 1-amino-4-hydroxy-2-ene derivatives. Herein we report the Cu(I)-DTBM-Segphos catalyzed asymmetric intermolecular NDA reaction of variously substituted cyclic 1,3-dienes using highly reactive nitroso compounds derived from pyrimidine and pyridazine derivatives. In most of the cases studied, the cycloadducts were obtained in high yields (up to 99%) with very high regio-, diastereo-, and enantioselectivities (up to regioselectivity > 99:1, d.r. > 99:1, and >99% ee). As an application of this methodology, formal syntheses of conduramine A-1 and narciclasine were accomplished.

Entities:  

Year:  2015        PMID: 26609961     DOI: 10.1021/jacs.5b11273

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Total Synthesis of Lycoricidine and Narciclasine by Chemical Dearomatization of Bromobenzene.

Authors:  Emma H Southgate; Daniel R Holycross; David Sarlah
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-23       Impact factor: 15.336

2.  Molecular mechanism of azoxy bond formation for azoxymycins biosynthesis.

Authors:  Yuan-Yang Guo; Zhen-Hua Li; Tian-Yu Xia; Yi-Ling Du; Xu-Ming Mao; Yong-Quan Li
Journal:  Nat Commun       Date:  2019-10-08       Impact factor: 14.919

Review 3.  Nitroso Diels-Alder Cycloadducts Derived From N-Acyl-1,2-dihydropyridines as a New Platform to Molecular Diversity.

Authors:  Andrea Menichetti; Francesco Berti; Mauro Pineschi
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

4.  α-Diimine synthesis via titanium-mediated multicomponent diimination of alkynes with C-nitrosos.

Authors:  Connor W Frye; Dominic T Egger; Errikos Kounalis; Adam J Pearce; Yukun Cheng; Ian A Tonks
Journal:  Chem Sci       Date:  2021-12-27       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.